Accordingly, we contrasted the expression level of IL-10, TGF-β, FOXP3, IL-6, and FAP between the high- and low-FMI groups, the outcome of which reconfirmed that strong immunosuppressive TME exists in BC patients with high FMI. The gene discussed is TGFB1; the disease is breast cancer.